Dr. Reckeweg R49 Rhinopulsan Combination Product while Breastfeeding
Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Dr. Reckeweg R49 Rhinopulsan Combination Product.

What is Dr. Reckeweg R49 Rhinopulsan Combination Product used for?

For the temporary relief of minor symptoms associated with sinusitis such as: Sinus headache Nasal congestion Sinus pressure and pain Runny nose Sneezing

Brief: Relieves symptoms associated with sinusitis

Is using Dr. Reckeweg R49 Rhinopulsan Combination Product unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Dr. Reckeweg R49 Rhinopulsan Combination Product safe while breastfeeding
FDA does not regulate Dr. Reckeweg R49 Rhinopulsan Combination Product. There is no credible study done on safety of Dr. Reckeweg R49 Rhinopulsan Combination Product while breastfeeding, Same holds truth for almost all homeopathic medicines however homeopathic medicines go through a process called potentisation. In potentisation homeopathic preparation goes through repeated dilution and shaking. Homeopaths state that repeated dilution and shaking helps the body to heal naturally. Due to extreme dilution of active ingredients homeopathic medicines are mostly safe in breastfeeding, Hence we can consider Dr. Reckeweg R49 Rhinopulsan Combination Product as safe to use while breastfeeding.. Below we have provided analysis of its active ingredients. Safety rating of ingredients holds truth for herbal product but may not apply for homeopathic diluted drugs.

Dr. Reckeweg R49 Rhinopulsan Combination Product Breastfeeding Analsys

Arsenic trioxide while Breastfeeding


Used in the treatment of promyelocitic leukemia in adults.

Oyster shell calcium carbonate, crude while Breastfeeding


CAS Number: 471-34-1

Various calcium salts (Acetate, Carbonate, Chloride, Citrate, Phosphate, Gluceptate, Glucobionato, Lactate, Laxctobionato Pidolate, Silicate) are used in the management of hypocalcemia, supplements for treating calcium deficiency states and antacids ( Carbonate and Silicate) Daily requirement of calcium during lactation are 1 g (1.3 g in children under 20 years).Calcium supplements in the diet does not affect the concentration of calcium in milk.Excessive intake of calcium is not good for health. During lactation, consumption of calcium should not exceed 2.5 g a day. WHO List of Essential Medicines 2002 states that it is compatible with breastfeeding.

Potassium dichromate while Breastfeeding


CAS Number: 7778-50-9

Así como el Cromo (véase ficha) en estado trivalente (3+) y a dosis apropiadas carece de toxicidad y constituye un oligoelemento nutricional esencial, las sales hexavalentes (6+) de cromo tienen usos industriales (cromado), son oxidantes, corrosivas, irritantes, están catalogadas como carcinogenos 1A y mutágenos 1B (INSHT 2012, ATSDR 2012), pueden causar dermatitis de contacto y toxicidad crónica y aguda grave.El cromo 6+ se encuentra también en el humo de combustión del tabaco, en cosméticos (Hepp 2014) y en algunas prótesis osteoarticulares (Oppermann 2015). Los compuestos de cromo exavalente, por su peligrosidad, no tienen actualmente usos médicos. A nivel de riesgo laboral para la madre lactante, las frases (INSHT 2008) de riesgo (antiguas frases R, actualmente frases H de Hazard, peligro) o de prudencia (frases P) que deben aparecer en la ficha de seguridad de un producto son sólo dos:- H362 (ant. R64): "Puede perjudicar a los niños alimentados con leche materna"- P263: "Evitar el contacto durante el embarazo y la lactancia"Otras tres frases que se deben considerar durante la lactancia tienen relación con el poder cancerígeno, mutagénico o acumulativo de un producto:- H351 (ant. R40): "Posibles efectos cancerígenos" - H371 (ant. R68): "Posibilidad de efectos irreversibles" - H373 (ant. R33): "Peligro de efectos acumulativos" Basándose en la ausencia de estas frases en las fichas de seguridad del trióxido de cromo (Panreac 2012, INSHT 2005), no sería preciso apartar a la madre lactante de su puesto de trabajo, bastándole a la empresa con cumplir las exigencias legales de valores máximos de exposición ambiental y a la trabajadora las normas aconsejadas de prudencia (guantes, lavado de manos, cambio de ropa, etc. (Panreac 2012). Pero según la normativa europea vigente (Reglamento CE 2008) cuando un producto es carcinógeno y mutágeno, las madres lactantes trabajadoras no deben estar expuestas a mezclas, sean de sólidos, líquidos o gases, con límites de concentración superiores a 0,3%.Además resulta un anomalía el que estando clasificado como cancerígeno 1A, no se le aplique la frase H351 (R40). A la luz de toda la bibliografía, consideramos que la madre lactante no debería estar expuesta a compuestos hexavalentes de cromo en el ambiente laboral.

Mercurius solubilis while Breastfeeding

Low Risk

CAS Number: 7439-97-6

Environmental pollutant that is used for manufacturation of batteries, fungicidal products, dental amalgam, and contaminated fish. Most of mercury present in breast milk does it as an inorganic substance which is almost non-absorbable. Breastfeeding should be discontinued whenever a mother is contaminated or intoxicated. It may be a source of neurological troubles. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other foods. (Codex alimentarius FAO-WHO).

Dr. Reckeweg R49 Rhinopulsan Combination Product Breastfeeding Analsys - 2

Arsenic trioxide while Breastfeeding

CAS Number: 1327-53-3

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]

Sulfur while Breastfeeding

CAS Number: 7704-34-9

Sulfur 5% to 10% in a petrolatum base is safe for topical use in children, including infants under 2 months of age.[1] This makes it a useful alternative to organic insecticides for treating scabies in nursing mothers; however, the petrolatum base makes undesirable for use on the breast.

Dr. Reckeweg R49 Rhinopulsan Combination Product Breastfeeding Analsys - 3

Sepia officinalis juice and Breastfeeding


SEPIA OFFICINALIS is usually low in mercury and its likely safe in breastfeeding.

Sulfur and Breastfeeding


Note: Study and data for tropical use only

Warning: Tropical usage in breast area shall be avoided to prevent the Thuja passing orally in Infants.

I already used Dr. Reckeweg R49 Rhinopulsan Combination Product and meanwhile I breastfed my baby should I be concerned?

Due to high dilution of ingredients in homeopathic medicines they do not create much problem for baby. Dr. Reckeweg R49 Rhinopulsan Combination Product is a homeopathic medicine and if your baby does not have any abnormal symptoms then there is nothing to worry about. Be careful with too much usage of ethanol based homeopathic medicines during breastfeeding.

My health care provider has asked me to use Dr. Reckeweg R49 Rhinopulsan Combination Product, what to do?

Homeopathic medicines are usually safe in breastfeeding and if Dr. Reckeweg R49 Rhinopulsan Combination Product has been recommended by doctor then there should be no concern about its usage in breastfeeding.

If I am using Dr. Reckeweg R49 Rhinopulsan Combination Product, will my baby need extra monitoring?

Not exactly.

Who can I talk to if I have questions about usage of Dr. Reckeweg R49 Rhinopulsan Combination Product in breastfeeding?

National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week